Medical approaches to primary sclerosing cholangitis.
Kaplan
M M
MM
Department of Medicine, New England Medical Center Hospitals, Boston, MA 02111.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000982:Antipruritics / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D015209:Cholangitis, Sclerosing / Q000150:complications / Q000188:drug therapy*; D002779:Cholestasis / Q000188:drug therapy / Q000209:etiology; D002792:Cholestyramine Resin / Q000627:therapeutic use; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000982:Antipruritics; D014815:Vitamins; D002792:Cholestyramine Resin; D014580:Ursodeoxycholic Acid; D015122:Mercaptopurine; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate